Mel Mann, MBA, M.Ed

Mel Mann was diagnosed with Chronic Myeloid Leukemia (CML) in 1995 at the age of 37. While serving in the Army, he was having persistent back pain and sought medical treatment. After an MRI, blood and marrow testing, he was officially diagnosed with cancer. After unsuccessful attempts to find a marrow donor, Mel joined a clinical trial for Gleevec. The drug trial was successful for Mel, and he has been able to manage his CML with medication for over 17 years. He enjoys being active and participating in his daughter’s milestones.